glp 1 drugs semaglutide GLP-1 Lower Risk of Death by 44% in Obesity and Autoimmune Disease GLP-1 weight-loss drugs may also

M.DeaconC

Mitochondrial support: Enhances mitochondrial respiration and reduces reactive oxygen species, at least in aging fibroblast models

The SELECT cardiovascular outcomes trial (N=17,604) demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean follow-up of 39.8 months, a finding that strengthens re-authorization arguments for patients with established cardiovascular disease [5]

CVS Health announced updates to its most common commercial formularies, expanding GLP-1 options for membersincluding the reintroduction of Zepbound (tirzepatide) as a covered medication

In a population based study from Olmstead county in Minnesota, the prevalence of gastroparesis was 24.2 per 100,000 persons for both genders, 9.6 per 100,000 for men and 37.8 per 100,000 for women [30]

Safety depends on the patient, the treatment plan, and careful medical review